BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pagnini C, Menasci F, Festa S, Rizzatti G, Fave GD. “Mucosal healing” in ulcerative colitis: Between clinical evidence and market suggestion. World J Gastrointest Pathophysiol 2014; 5(2): 54-62 [PMID: 24891976 DOI: 10.4291/wjgp.v5.i2.54]
URL: https://www.wjgnet.com/2150-5330/full/v5/i2/54.htm
Number Citing Articles
Cristiano Pagnini, Francesca Menasci, Federico Desideri, Vito D. Corleto, Gianfranco Delle Fave, Emilio Di Giulio. Endoscopic scores for inflammatory bowel disease in the era of ‘mucosal healing’: Old problem, new perspectivesDigestive and Liver Disease 2016; 48(7): 703 doi: 10.1016/j.dld.2016.03.006
Joshua M. Royal, Micaela A. Reeves, Nobuyuki Matoba. Repeated Oral Administration of a KDEL-Tagged Recombinant Cholera Toxin B Subunit Effectively Mitigates DSS Colitis despite a Robust Immunogenic ResponseToxins 2019; 11(12): 678 doi: 10.3390/toxins11120678
Klaus R. Herrlinger, Eduard F. Stange. Twenty‐five years of biologicals in IBD: What´s all the hype about?Journal of Internal Medicine 2021;  doi: 10.1111/joim.13345
Jon Florholmen. Mucosal healing in the era of biologic agents in treatment of inflammatory bowel diseaseScandinavian Journal of Gastroenterology 2015; 50(1): 43 doi: 10.3109/00365521.2014.977943
Gary R. Lichtenstein. Budesonide Multi-matrix for the Treatment of Patients with Ulcerative ColitisDigestive Diseases and Sciences 2016; 61(2): 358 doi: 10.1007/s10620-015-3897-0
Silvia Nardelli, Laura Francesca Pisani, Gian Eugenio Tontini, Maurizio Vecchi, Luca Pastorelli. MMX® technology and its applications in gastrointestinal diseasesTherapeutic Advances in Gastroenterology 2017; 10(7): 545 doi: 10.1177/1756283X17709974
Antonio Tursi. Managing Patients with Ulcerative Colitis with Infliximab in Primary and Referral Gastroenterology CentersInflammatory Bowel Diseases 2014; 20(12): E24 doi: 10.1097/MIB.0000000000000252